mixed survival data
GSK Reports Mixed Results for Jemperli/Zejula Combination in First-Line Ovarian Cancer Trial
GSK, Jemperli, Zejula, ovarian cancer, first-line treatment, mixed survival data, clinical trial results
Actionable Insights Powered by AI
GSK, Jemperli, Zejula, ovarian cancer, first-line treatment, mixed survival data, clinical trial results